Biofilm Disruption Enhances Antimicrobial Therapy for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen...

Area of Science:

• Microbiology
• Gastroenterology
• Pharmacology

Background:

• Small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) are microbial dysbiosis conditions linked to various gastrointestinal and systemic issues.
• Herbal antimicrobials are explored as non-antibiotic alternatives to rifaximin for SIBO/IMO treatment.
• Biofilm-related resistance can impede the efficacy of both pharmaceutical and herbal antimicrobial treatments.

Purpose of the Study:

• To evaluate the effectiveness of incorporating a biofilm disruptor into herbal antimicrobial therapy for SIBO/IMO.
• To assess the impact on eradication rates and microbial gas levels (hydrogen and methane).

Main Methods:

• A retrospective chart review of 13 patients with SIBO/IMO, diagnosed via lactulose breath testing.
• Patients were randomized into two groups over 8 weeks: herbal antimicrobials alone (control, n=5) or herbal antimicrobials with biofilm disruptors (treatment, n=8).

Main Results:

• The treatment group showed significantly greater reductions in hydrogen (-30.75 ppm) and methane (-26.38 ppm) levels compared to the control group.
• While SIBO eradication rates were high (60-100%) in both groups, no statistically significant difference was observed.
• Neither group achieved complete eradication of IMO.

Conclusions:

• Combining biofilm disruptors with herbal antimicrobials enhances the reduction of hydrogen and methane gas levels in SIBO/IMO.
• Current herbal protocols, with or without biofilm agents, show comparable SIBO eradication rates to rifaximin, though not statistically significant due to sample size.
• Larger prospective studies are necessary to validate these preliminary findings and establish the role of biofilm disruptors in managing SIBO/IMO.